ANEBULO PHARMACEUTICALS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
ANEBULO PHARMACEUTICALS, INC. (ANEB) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 889.84 thousand shares for the 12-month period ending 2024-06-30, per its 10-K filed 2024-09-25.
Financial Statements › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2024-09-25
- ANEBULO PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2024-06-30 was 0.00 shares.
- ANEBULO PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2024-03-31 was 437.60K shares.
- ANEBULO PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2023-12-31 was 447.82K shares.
- ANEBULO PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2023-09-30 was 4.42K shares.
- ANEBULO PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 889.84K shares, a 8139.24% increase from fiscal 2023.
- ANEBULO PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 10.80K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|---|---|
| 2024-06-30 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-25 | 437.60K shares derived: sum of 2 quarters · filed 2024-09-25 | 885.42K shares derived: sum of 3 quarters · filed 2024-09-25 | 889.84K shares 10-K · filed 2024-09-25 |
| 2024-03-31 | 437.60K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-15 | 885.42K shares derived: sum of 2 quarters · filed 2024-05-15 | 889.84K shares 10-Q · filed 2024-05-15 | 889.84K shares derived: sum of 4 quarters · filed 2024-05-15 |
| 2023-12-31 | 447.82K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-13 | 452.24K shares 10-Q · filed 2024-02-13 | 452.24K shares derived: sum of 3 quarters · filed 2024-02-13 | |
| 2023-09-30 | 4.42K shares 10-Q · filed 2023-11-14 | 4.42K shares derived: sum of 2 quarters · filed 2023-11-14 | ||
| 2023-06-30 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-22 | 10.80K shares 10-K · filed 2023-09-22 | ||
| 2023-03-31 | 10.80K shares 10-Q · filed 2023-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |